Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027

Loading news article.

Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027 | WAPE

Alpha Tau Medical Announces Completion Of Enrollment Of 48 Patients In Phase Pilot IMPACT Study Of Alpha DaRT With First-Line Chemotherapy In Unresectable Pancreatic Cancer; Targets Initial Data Early 2027

Article summary

Related companies

Comments —